English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Bioceres Crop Solutions Subsidiary Rizobacter Argentina S.A. Completes $26.0 Million Offering of Series V Corporate Bondsqrcode

Mar. 9, 2021

Favorites Print
Forward
Mar. 9, 2021

Bioceres Crop Solutions Corp. ("Bioceres" or the "Company"), a fully-integrated global provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced that its subsidiary Rizobacter Argentina S.A. ("Rizobacter") has completed a $26.0 million public offering of Series V corporate bonds in the Argentine market. The bonds were issued in two tranches:


Class A: $5.2 million with maturity in March 2022 and an annual nominal interest rate of 0.98%; and


Class B: $20. 8 million with maturity in March 2024 and an annual nominal interest rate of 5.5%.


Proceeds will be used to support working capital, extend debt maturities, and reduce financing costs, as well as for general corporate purposes.


Mr. Enrique Lopez Lecube, Chief Financial Officer of Bioceres, said: "This issuance is aligned with our overall strategy to further stabilize debt structure by extending maturities, and to continue strengthening our liquidity position. With this transaction we also secured working capital requirements to continue advancing our HB4 Program efforts, as well as expanding the global footprint of our key biological products. Moreover, it is encouraging to see the continued support and strong demand from investors for these follow-on public offerings thus demonstrating the confidence in Bioceres’ commercial progress and our disruptive crop productivity technology platform," concluded Lopez Lecube.


0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe Latin America Focus Bi-weekly to send news related to your mailbox